0.1295

9.19% -0.0131

After Hours: .12 -0.0095 -7.34%

Liminatus Pharma Inc (LIMN)

Overview News Price History Discussions Forecast

Liminatus Pharma Inc stock is traded at $0.1295, with a volume of 11.34M. It is down -9.19% in the last 24 hours and down -8.93% over the past month. Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The company is developing a next generation CD47 immune checkpoint inhibitor that enables cancer cells to evade detection by the immune system. Anti-CD47 monoclonal antibodies generally induce anemia and thrombocytopenia due to their binding to red blood cells and platelets. The Liminatus CD47 mAb has shown to preferentially bind to immune cells, but not to red blood cells and platelets and does not induce hemolysis. The clinical candidate is currently in the late preclinical stage.

Previous Close:

$0.1426

Open:

$0.124

24h Volume:

11.34M

Relative Volume:

0.62

Market Cap:

$6.55M

Revenue:

Net Income/Loss:

$-11.00M

P/E Ratio:

-0.3274

EPS:

-0.3956

Net Cash Flow:

$-11.99M

1W Performance:

+17.30%

1M Performance:

-8.93%

6M Performance:

-86.22%

1Y Performance:

-98.13%

1-Day Range:

$0.11

$0.1389

1-Week Range:

$0.0962

$0.207

52-Week Range:

$0.095

$9.38

Liminatus Pharma Inc Stock (LIMN) Company Profile

Name

Liminatus Pharma Inc

Sector

Healthcare (1094)

Industry

Biotechnology (615)

Phone

213-273-5453

Address

12611 HIDDENCREEK WAY, CERRITOS

Employee

Twitter

Next Earnings Date

2026-06-30

Latest SEC Filings

LIMN's Discussions on Twitter

Compare LIMN vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LIMN Liminatus Pharma Inc	0.1295	7.22M	0	-11.00M	-11.99M	-0.3956
VRTX Vertex Pharmaceuticals Inc	522.25	134.41B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	676.23	68.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.94	57.01B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	321.59	41.79B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	190.46	40.39B	742.00K	-1.37B	-1.07B	-7.0731

Liminatus Pharma Inc Stock (LIMN) Latest News

08:05 AM

Liminatus Pharma (LIMN) stock is trending overnight — here’s why it spiked over 30% in after-hours session (updated) - MSN

Jul 02, 2026

Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Sessio - Benzinga

Jul 02, 2026

Jun 30, 2026

Liminatus amends InnocsAI merger, closing set for July 2 - Investing.com

Jun 30, 2026

Trending Stocks Today | LogProStyle Surges 72.41% Post-Market - Moomoo

Jun 30, 2026

Wondering what's happening in today's after-hours session? - ChartMill

Jun 30, 2026

Liminatus amends InnocsAI merger, closing set for July 2 By Investing.com - Investing.com Canada

Jun 30, 2026

Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline - The Manila Times

Jun 30, 2026

Liminatus pushes $320M InnocsAI merger to July 2 close - Stock Titan

Jun 30, 2026

Form PRE 14A Liminatus Pharma Inc For: 30 June By Investing.com - Investing.com Nigeria

Jun 30, 2026

Liminatus Pharma (LIMN) Edges Higher Amid Penny Stock VolatilityVolatility Stop - dars.gov.et

Jun 30, 2026

Jun 26, 2026

Liminatus Pharma (LIMN) Stock Forum and Discussion - Moomoo

Jun 26, 2026

Jun 24, 2026

Form S-1 Liminatus Pharma Inc For: 24 June By Investing.com - Investing.com Nigeria

Jun 24, 2026

Liminatus (NASDAQ: LIMN) resale S-1 and 1.6B-share InnocsAI merger plan - Stock Titan

Jun 24, 2026

Jun 14, 2026

Liminatus Pharma (LIMN) Faces Selling Pressure, Testing Key Support at $0.11Money Flow - newsline.com

Jun 14, 2026

Liminatus Pharma Warrants (LIMNW) Holds at $0.08 as Trading StallsPut Flow Alert - newsline.com

Jun 14, 2026

Jun 12, 2026

Liminatus Pharma (LIMN) Extends Decline, Testing Key Support at $0.11OBV Breakout - newsline.com

Jun 12, 2026

Jun 09, 2026

Liminatus Pharma Warrants (LIMNW) Hold Steady Near Key Support LevelVolume Oscillator - newsline.com

Jun 09, 2026

Jun 08, 2026

Liminatus Pharma (LIMN) Slips 5.77% as Selling Pressure Persists Below $0.14 ResistanceJelly Roll Trade - newsline.com

Jun 08, 2026

Jun 07, 2026